Skip to main content
Print Save

Skyrizi Prices, Coupons and Patient Assistance Programs

Skyrizi (risankizumab) is a member of the interleukin inhibitors drug class and is commonly used for Crohn's Disease, Plaque Psoriasis, Psoriasis, and others.

Skyrizi prices

The cost for Skyrizi subcutaneous kit (75 mg/0.83 mL) is around $19,251 for a supply of 1 kits, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Skyrizi price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Subcutaneous Kit

Subcutaneous Solution

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Skyrizi Coupons and Rebates

Skyrizi offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Skyrizi Complete Savings Card: Eligible commercially insured patients may pay as little as $5 per quarterly dose; annual maximum savings of $6,000.00 per calendar year; for additional information contact the program at 866-759-7494.

Applies to:
Skyrizi
Number of uses:
once per quarter

Form more information phone: 866-759-7494 or Visit website

Skyrizi Complete Savings Card Rebate: Eligible commercially insured patients may submit a rebate request if unable to use the savings card at their pharmacy; for additional information contact the program at 866-759-7494.

Applies to:
Skyrizi
Number of uses:
One rebate per prescription fill

Form more information phone: 866-759-7494 or Visit website

Skyrizi Medicare Part D Extra Help Subsidy: Patients who have Medicare Part D coverage may be eligible to apply for the Part D Extra Help Subsidy and once accepted to the program may pay $9.20 or less per monthly prescription; contact the program directly for questions or to sign-up.

Applies to:
Skyrizi
Number of uses:
Per prescription until program expires

Form more information phone: 800-772-1213 or Visit website

Patient Assistance Programs for Skyrizi

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Skyrizi Complete Sharps Disposal Program

Elligibility requirements:
  1. Not specified
  2. Not Required
  3. Not specified
  4. Must be a US resident and treated by a US licensed healthcare provider
  5. Patient enrolls to receive a free sharps container.
Applicable drugs:
  • Skyrizi (container for skyrizi) Disposal Container

More information please phone: 866-759-7494 Visit Website

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Skyrizi (risankizumab-rzaa) Injection; Subcutaneous

More information please phone: 866-316-7263 Visit Website

Provider: myAbbVie Assist for Skyrizi

Elligibility requirements:
  1. Must be uninsured or underinsured
  2. At or below 600% of FPL
  3. Not applicable
  4. Must reside in the US and be under the direct care of a US physician
  5. Any patient who requires the medication and are in need should call the company. Eligibility determined on a case-by-case basis. Patients with prescription drug coverage may be eligible on exception basis. Contact program for details.
Applicable drugs:
  • Skyrizi (risankizumab-rzaa) Injection; Subcutaneous

More information please phone: 800-222-6885 Visit Website